A Study to Evaluate the Safety, Tolerability, and Efficacy of the Addition of Omarigliptin (MK-3102) to Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin Therapy (MK-3102-024)

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 402 participants.

Also called NCT01755156

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 402 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01755156
  • EudraCT 2012-003670-11
Other papers using this trial's data
  • A randomized clinical trial evaluating the efficacy and safety of the once-weekly dipeptidyl peptidase-4 inhibitor omarigliptin in patients with type 2 diabetes inadequately controlled on metformin monotherapy Current medical research and opinion, 2017-10 DOI, PubMed 28547998

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
Not reported
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01755156. Randomized; triple masking; primary purpose treatment. Start 2013-01-11 (actual); primary completion 2016-03-16 (actual). Results posted on 2017-03-20.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Study to Evaluate the Safety, Tolerability, and Efficacy of the Addition of Omarigliptin (MK-3102) to Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin Therapy (MK-3102-024)
Condition
Type 2 Diabetes Mellitus
Intervention (Drug)
Omarigliptin
Intervention (Drug)
Matching placebo to omarigliptin
Intervention (Drug)
Glimepiride
Intervention (Drug)
Matching placebo to glimepiride
Intervention (Drug)
Insulin glargine
Intervention (Drug)
Metformin
Lead sponsor
Merck Sharp & Dohme LLC (class: industry)

Record details

Record id
cardio:ct-nct01755156
Content hash
03b76d8c400283375ccd419724fa034de7b2b9760025562dce1e2ab9cbde7d2d